Researchers found that the World Health Organization (WHO) Ebola case definition has a specificity of only 31.5%, and they noted that 9% of Ebola patients reported neither a fever nor any Ebola risk exposure, calling into question WHO norms, according to a large study yesterday in The Lancet Infectious Diseases.
Middle East respiratory syndrome coronavirus (MERS-CoV) has sickened four more people in Saudi Arabia in the past 2 days, one of them fatally, according to reports from the country's Ministry of Health (MOH).
With 26 new cases, much activity is centered in the two capitals for the 2nd week in a row.
The contract is for bolstering monoclonal antibody treatment for Ebola.
A convalescent plasma trial shows early promise, and a report indicates extended virus shedding in urine and stool.
Data from a hospital outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) cases last spring suggest continuous healthcare-associated transmission for several months, a study today in Emerging Infectious Diseases noted.
Studies note frequent corpse touching at funerals, as well as frequent bat exposure.
Also, phase 2 trials just launched for two prime-boost Ebola vaccine regimens.
The string of cases that recently ended Liberia's respite has grown to 6 with the death of a woman in a Monrovia hospital.
Meanwhile, about 200 health leaders are meeting in Cape Town this week to discuss global health security priorities.
